来自Athenaea velutina (Sendtn.) 叶子中的生物活性维他诺化物. 达尔西 (D'Arcy) 的意思是
Késya Amanda Dantas Rocha1, Edilberto Rocha Silveira1, Tércio de Freitas Paulo1
1Departamento de Química Orgânica e Inorgânica, Centro de Ciências, Universidade Federal do Ceará, 60021-970, Fortaleza, CE, Brazil.
Phytochemistry
|May 25, 2025
概括
从Athenaea velutina的叶子中发现了十种新的维他诺化物. 一些化合物表现出对癌细胞的选择性细胞毒性和心性活性,而不会增加心率.
科学领域:
- 自然产品 化学 化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 维他诺化物是一种多样化的自然存在的类固醇乳,具有已知的生物活性.
- 植物Athenaea velutina (Solanaceae) 是潜在的生物活性化合物的来源.
- 以前的研究已经确定了这种植物具有药理性质的维他诺化物.
研究的目的:
- 从Athenaea velutina叶子中分离和阐明新型维他诺化物的结构.
- 评估与各种人类癌症细胞系对抗分离的维他诺利德的抗增殖和细胞毒性活动.
- 评估选择的维他诺化物对几内亚猪心脏组织的心脏动作用.
主要方法:
- 提取使用/EtOAc溶剂混合物的Athenaea velutina叶子.
- 使用全面的光谱分析 (NMR,HRESIMS) 和X射线衍射,阐明了十种新的维他诺化物 (1-10) 的结构.
- 在体外抗增殖测定对中枢神经系统,前列腺,结肠和白血病癌细胞系,以及小鼠纤维细胞.
- 在几内亚猪心脏组织中对心脏动活性进行药理学评估.
主要成果:
- 在已知的化合物旁边,分离和结构性表征了十种新型维他诺化物 (1-10),以及已知的化合物.
- 化合物15和16对所有测试的癌症细胞系表现出广泛的细胞毒性活性.
- 化合物2对HL-60白血病细胞表现出选择性细胞毒性.
- 化合物15和16表现出心力发动活性,可望缺乏积极的慢性作用.
结论:
- 该研究成功地确定了来自Athenaea velutina的新型维他诺化物,扩大了这一类已知的化学多样性.
- 几种维他诺化物具有显著的抗增殖和选择性细胞毒性,突出了它们作为抗癌剂的潜力.
- 化合物15和16的心性活性表明它们可能成为具有更好的安全性概况的新型无otropic 药物.
更多相关视频
08:03Unveiling Xenobiotic Transport and Effects in Isolated Mitochondria: Insights from Respirometric and Enzymatic Assays
Published on: March 7, 2025
703
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
2.6K
相关概念视频
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
917
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
917
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
01:26Heart Failure Drugs: Inotropic Agents
750
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
750
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
650
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
650
01:17Antihypertensive Drugs: Action of β1 Blockers
636
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
636
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
712
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
712